What is pathophysiology of Lung cancer?

Mvetserani tsamba ili

Kodi pathophysiology ya khansa ya m'mapapo ndi yotani?

Pathophysiology ya khansa ya m'mapapo imatanthauza kusintha kwa njira za thupi ndi njira zomwe zimachitika pakukula ndi kupita patsogolo kwa khansa ya m'mapapo.

Khansa ya m'mapapo ndi matenda ovuta kwambiri amene amayamba chifukwa cha kukula ndi kugaŵanika kosalamulirika kwa maselo a m'mapapo.

Maselo ameneŵa angapangitse zotupa ndi kufalikira ku mbali zina za thupi, kutsogolera ku zizindikiro ndi mavuto osiyanasiyana.

Matenda a khansa ya m'mapapo amaphatikizapo zinthu zingapo, kuphatikizapo kusintha kwa majini, zinthu za m'chilengedwe, ndi njira ya moyo.

Kusintha kwa majini kungachitike mu DNA ya maselo a m'mapapo, kuchititsa kukula kwa maselo ndi kugaŵikana kosalamulirika.

Kusintha kumeneku kungakhale kwa choloŵa kapena kupezeka, ndipo kungayambitsidwe ndi zinthu zimene zimayambitsa kansa, monga utsi wa fodya, radon, asbestos, ndi kuipitsa mpweya.

Khansa ya m'mapapo imatha kugawidwa m'mitundu iwiri: khansa ya m'mapapo ya maselo ang'onoang'ono (SCLC) ndi khansa ya m'mapapo ya maselo osakhala ang'onoang'ono (NSCLC). NSCLC imagawidwa m'magulu atatu: adenocarcinoma, squamous cell carcinoma, ndi large cell carcinoma.

Matenda a khansa ya m'mapapo a mitundu imeneyi angakhale osiyana, chifukwa ali ndi kusintha kwa majini kosiyana ndipo amayankha mosiyana pa chithandizo.

Pathophysiology ya khansa ya m'mapapo imaphatikizaponso kuyanjana pakati pa maselo a khansa ndi minofu yozungulira, kuphatikizapo chitetezo cha m'thupi.

Maselo a khansa amatha kuthawa chitetezo cha m'thupi, n'kulola kuti akule ndi kufalikira popanda kuletsedwa.

Kuphatikiza apo, microenvironment ya chotupa imatha kulimbikitsa kukula kwa chotupa ndi metastasis popereka malo othandizira maselo a khansa.

Pathophysiology ya khansa ya m'mapapo ndi njira yovuta ndi yosinthasintha, ndipo ofufuza akugwira ntchito mosalekeza kuti amvetsetse bwino njira zoyendetsera kuti apange mankhwala othandiza kwambiri ndikuwongolera zotsatira za odwala.

Maumboni othandiza

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.

Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.

Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.

Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .

Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .

Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.

Chodzikanira: zachipatala

Webusaitiyi imaperekedwa kaamba ka zolinga za maphunziro ndi chidziŵitso zokha ndipo si kupereka uphungu wa zachipatala kapena mautumiki a akatswiri.

Chidziŵitso choperekedwacho sichiyenera kugwiritsiridwa ntchito kupenda kapena kuchiza vuto la thanzi kapena matenda, ndipo awo ofuna uphungu waumoyo waumwini ayenera kufunsa dokotala wovomerezeka.

Chonde dziŵani kuti ma neural net amene amapanga mayankho a mafunso, ndi osayenerera makamaka pankhani ya manambala. Mwachitsanzo, chiŵerengero cha anthu odwala matenda enaake.

Nthawi zonse funsani upangiri wa dokotala wanu kapena wothandizira wina waluso pankhani ya matenda. Musanyalanyaze upangiri wa zamankhwala kapena kuchedwetsa kufunafuna chifukwa cha china chake chomwe mwawerenga patsamba lino. Ngati mukuganiza kuti mungakhale ndi vuto ladzidzidzi, itanani 911 kapena pitani ku chipinda chadzidzidzi chapafupi nthawi yomweyo. Palibe ubale wa dokotala ndi wodwala womwe umapangidwa ndi tsamba ili kapena kugwiritsa ntchito kwake. Neither BioMedLib kapena antchito ake, kapena aliyense wothandizira patsamba lino, amapanga ziwonetsero zilizonse, zowonetsera kapena zomveka, zokhudzana ndi chidziwitso choperekedwa pano kapena kugwiritsa ntchito kwake.

Chodzikanira: ufulu wolemba

Lamulo la Digital Millennium Copyright Act la 1998, 17 U.S.C. § 512 (the DMCA) limapereka njira yothandizira eni ake omwe amakhulupirira kuti zinthu zomwe zikuwonekera pa intaneti zimaphwanya ufulu wawo pansi pa lamulo la copyright la US.

Ngati mukukhulupirira mokhulupirika kuti zomwe zili patsamba lathu kapena ntchito zathu zikuphwanya ufulu wanu, inu (kapena wothandizila wanu) mutha kutitumizira chidziwitso chofuna kuti zomwe zili patsamba lathu kapena zinthuzo zichotsedwe, kapena kutsekedwa.

Zidziwitso ziyenera kutumizidwa polemba kudzera pa imelo (onani gawo la "Contact" pa adilesi ya imelo).

DMCA imafuna kuti chidziwitso chanu cha kuphwanya ufulu waumwini chiphatikizepo chidziwitso chotsatirachi: (1) kufotokoza kwa ntchito yotetezedwa ndi ufulu waumwini yomwe ndi nkhani ya kuphwanya ufulu waumwini; (2) kufotokoza kwa zomwe zikunenedwa kuti zikuphwanya ufulu waumwini ndi chidziwitso chokwanira kutilola kupeza zomwe zili; (3) zidziwitso zolumikizirana nanu, kuphatikiza adilesi yanu, nambala yafoni ndi adilesi ya imelo; (4) mawu anu oti muli ndi chikhulupiriro chabwino kuti zomwe zili m'njira yomwe akudandaula sizinaloledwe ndi mwiniwake wa ufulu waumwini, kapena wothandizila wake, kapena chifukwa cha lamulo lililonse;

(5) chikalata chanu, chosainidwa pansi pa chilango cha umboni wabodza, chakuti chidziŵitso chimene chili m'chidziŵitsocho n'cholondola ndipo kuti muli ndi ulamuliro wokakamiza kukhazikitsa ufulu waumwini umene akunena kuti waphwanyidwa;

ndi (6) siginecha yakuthupi kapena yamagetsi ya mwiniwake wa ufulu waumwini kapena munthu wololedwa kuchitapo kanthu m'dzina la mwiniwake wa ufulu waumwini.

Kulephera kuphatikizapo chidziŵitso chonse chapamwamba kungayambitse kuchedwa kwa kusanthula madandaulo anu.

Kulumikizana

Chonde titumizireni imelo ndi funso / lingaliro lililonse.

What is pathophysiology of lung cancer?

The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.

Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.

These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.

The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.

Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.

These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.

Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.

The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.

Cancer cells can evade the immune system, allowing them to grow and spread unchecked.

Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.

The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.